Key facts
- This page summarizes Joseph C. Ventura's Form 4 filing for HUMANA INC (HUM).
- 1 reported transaction and 5 derivative rows are listed below.
- Accepted by SEC: 05 May 2026, 13:33.
Joseph C. Ventura - 01 May 2026 Form 4 Insider Report for HUMANA INC (HUM)
- Reporting relationship
- Chief Legal Officer
- Issuer ticker
- HUM
- Reported as of
- 01 May 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 05 May 2026, 13:33:28 UTC
- Prior SEC filing
- 26 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- Joseph C. Ventura
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Joseph C. Ventura filed Form 4 for HUMANA INC (HUM) on 05 May 2026.
Change
- Previous filing in this sequence was filed on 26 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001768291
Primary reporting owner
Ventura Joseph C
- Relationship
- Chief Legal Officer
- Address
- HUMANA INC., 101 E. MAIN STREET, LOUISVILLE
- Signature
- Joseph C. Ventura
- Signature date
- 05 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
HUM
transaction
Humana Common
Award
- Transaction value
- Shares
- +10,318
- Change %
- +60%
- Price
- $0.000000*
- Shares after
- 27,405
- Date
- 01 May 2026
- Ownership
- Direct
- Footnotes
- F7
HUM
holding
Humana Common
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 294
- Date
- 01 May 2026
- Ownership
- See Footnote
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,656
- Date
- 01 May 2026
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 4,656
- Exercise price
- $350.79
- Footnotes
- F2
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,598
- Date
- 01 May 2026
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 4,598
- Exercise price
- $376.61
- Footnotes
- F3
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,932
- Date
- 01 May 2026
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 3,932
- Exercise price
- $425.06
- Footnotes
- F4
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,162
- Date
- 01 May 2026
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 4,162
- Exercise price
- $510.24
- Footnotes
- F5
HUM
holding
Derivative
Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 6,572
- Date
- 01 May 2026
- Ownership
- Direct
- Underlying class
- Humana Common
- Underlying amount
- 6,572
- Exercise price
- $367.21
- Footnotes
- F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
Shares held for the benefit of reporting person as of April 30, 2026 under the Humana Retirement Savings Plan including routine payroll deductions, quarterly dividend allocation, and a routine disposition of shares to fund an administrative fee assessment under a Tax-Conditioned Plan, exempt under Rule 16b-3(c).
Footnote F2
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2020, vesting in three annual increments from 2/24/21 to 2/24/23.
Footnote F3
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/22/2021, vesting in three annual increments from 2/22/22 to 2/22/24.
Footnote F4
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2022, vesting in three annual increments from 2/21/23 to 2/21/25.
Footnote F5
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/24/2023, vesting in three annual increments from 2/24/24 to 2/24/26.
Footnote F6
Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 02/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.
Footnote F7
Includes 16,568 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan and 2026 Stock Incentive Plans.